US · SGRY
Surgery Partners, Inc.
- Sector
- Healthcare · Medical - Care Facilities
- Headquarters
- Brentwood, TN 37027
- Website
- surgerypartners.com
Price · as of 2024-12-31
$14.27
Market cap 2B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $48.68 | +241.14% |
| Intrinsic Value(DCF) | $9.62 | -32.59% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | $0.00 | $0.00 | |||
| 2015 | $16.00 | $73.84 | $2,628.48 | $0.00 | $5.55 |
| 2016 | $18.85 | $48.15 | $542.17 | $0.00 | $5.25 |
| 2017 | $17.30 | $90.46 | $364.24 | $0.00 | $0.00 |
| 2018 | $11.33 | $83.26 | $43.52 | $0.00 | $0.00 |
| 2019 | $10.76 | $82.47 | $0.00 | $0.00 | $0.00 |
| 2020 | $42.06 | $85.86 | $0.00 | $0.00 | $0.00 |
| 2021 | $54.03 | $70.50 | $0.00 | $0.00 | $0.00 |
| 2022 | $30.29 | $49.23 | $3.71 | $0.00 | $0.00 |
| 2023 | $29.50 | $41.87 | $5.74 | $0.00 | $0.00 |
| 2024 | $24.05 | $48.68 | $9.88 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Surgery Partners, Inc.'s (SGRY) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $48.68
- Current price
- $14.27
- AI upside
- +241.14%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$9.62
-32.59% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SGRY | Surgery Partners, Inc. | $14.27 | 2B | +241% | -33% | — | — | 242.66 | 1.69 | 0.97 | 12.90 | 18.60 | -0.91 | 23.94% | 11.20% | -5.40% | 0.66% | 2.77% | 0.17% | 2.07 | 1.73 | 1.79 | 1.36 | 6.85 | 130444.00% | 1352.00% | 229.00% | 6.91% | 0.48 | 4.16% | 0.00% | 0.00% | 0.00% | 18.54 | 30.84 | 2.08 | 0.91 |
| ARDT | Ardent Health Partners, L… | $9.39 | 1.34B | +968% | -38% | +7% | +203% | 6.44 | 1.71 | 0.32 | 6.36 | 1.83 | 9.54 | 82.68% | 6.80% | 3.53% | 33.26% | 12.21% | 5.96% | 2.02 | 6.19 | 1.94 | 1.37 | 3.00 | 35143.00% | 1029.00% | 5128.00% | 6.60% | 0.33 | 4.65% | 0.00% | 0.00% | 12.10% | 9.01 | 28.67 | 0.61 | 2.13 |
| ATEC | Alphatec Holdings, Inc. | $13.62 | 2.02B | +183% | +162% | — | — | -14.10 | 56.10 | 2.65 | -62.48 | — | -15.24 | 69.60% | -10.75% | -18.76% | -630.66% | -16.83% | -18.30% | 17.21 | -3.88 | 2.06 | 1.18 | -11.57 | -1504.00% | 2495.00% | -10201.00% | 0.14% | 0.21 | 0.57% | 0.00% | 0.00% | 0.59% | -30.20 | 893.55 | 3.25 | 0.06 |
| BKD | Brookdale Senior Living I… | $15.30 | 3.64B | +32% | -60% | — | — | -13.49 | -79.22 | 1.13 | 28.56 | -54.59 | -49.19 | 20.64% | 0.55% | -8.41% | -313.31% | 0.29% | -4.28% | -148.91 | 0.07 | 3.62 | 2.26 | 18.37 | 2472.00% | 477.00% | 73974.00% | -8.31% | 1.42 | -4.96% | 0.00% | 0.00% | 0.18% | 578.45 | -33.72 | 3.18 | -0.04 |
| CDTX | Cidara Therapeutics, Inc. | $221.38 | 5.61B | -67% | -96% | — | +934% | -0.88 | 0.92 | 117.83 | 0.20 | -0.22 | 0.92 | -6557.49% | -13811.92% | -13319.76% | -218.99% | 567.59% | -120.52% | 0.02 | — | 4.25 | 3.86 | 1.06 | 40952.00% | -9800.00% | 67021.00% | -117.59% | -3.56 | 569.40% | 0.00% | 0.00% | 103.41% | 0.20 | 0.20 | -28.25 | -4.03 |
| HTFL | Heartflow, Inc. Common St… | $23.16 | 1.97B | — | — | — | — | — | — | — | — | — | — | 75.07% | -48.66% | -76.65% | 11.78% | 8.22% | -63.49% | -0.19 | -2.69 | 2.45 | 2.33 | -1.67 | -2320.00% | 4432.00% | -1112.00% | — | -2.05 | 9.85% | — | 0.00% | — | — | — | — | — |
| IDYA | IDEAYA Biosciences, Inc. | $32.20 | 2.83B | +1,323% | +773% | -84% | — | -25.71 | 2.86 | 13.37 | -14.94 | — | 2.86 | 97.90% | -72.84% | -51.99% | -10.92% | -39.17% | -10.18% | 0.03 | — | 11.34 | 10.87 | 0.55 | -6190.00% | 302443.00% | -7078.00% | -2.51% | -1.21 | -18.06% | 0.00% | 0.00% | 0.67% | -14.51 | -31.47 | 10.57 | 19.76 |
| LEGN | Legend Biotech Corporatio… | $19.00 | 1.75B | +139% | +396,718% | -91% | — | -20.39 | 3.10 | 5.14 | -21.66 | — | 3.72 | 62.60% | -48.35% | -28.22% | -13.80% | -112.36% | -8.99% | 0.34 | -14.03 | 4.62 | 4.49 | -0.56 | -6701.00% | 11997.00% | -6199.00% | -4.91% | -0.52 | -58.59% | 0.00% | 0.00% | 0.00% | -8.08 | -15.50 | 3.91 | 2.18 |
| LIVN | LivaNova PLC | $70.60 | 3.86B | +8% | -48% | — | — | -15.79 | 3.19 | 2.76 | -28.32 | — | 21.61 | 67.71% | 14.36% | -17.47% | -19.24% | 15.30% | -9.49% | 0.39 | 4.04 | 1.36 | 1.05 | 1.25 | -48362.00% | 1074.00% | 2742.00% | 4.52% | 0.31 | 13.29% | 0.00% | 0.00% | 10.83% | 18.39 | 21.17 | 2.64 | 2.55 |
| SRRK | Scholar Rock Holding Corp… | $44.27 | 4.52B | — | — | — | — | -14.59 | 9.75 | — | -13.57 | -60.50 | 9.81 | 0.00% | — | — | -82.95% | -14081.23% | -62.67% | 0.18 | -36.87 | 9.61 | 9.36 | 0.47 | 2412.00% | — | 3837.00% | -5.59% | -4.28 | -11231.68% | 0.00% | 0.00% | 2.02% | -12.78 | -16.03 | — | 16.84 |
| ZLAB | Zai Lab Limited | $19.22 | 2.13B | +50% | -49% | — | — | -11.49 | 2.82 | 4.38 | -9.81 | — | 3.16 | 58.60% | -49.86% | -38.15% | -22.56% | -97.09% | -14.89% | 0.31 | -44.05 | 2.45 | 1.91 | 2.88 | -3846.00% | 1533.00% | -4251.00% | -7.88% | -0.36 | -68.36% | 0.00% | 0.00% | 7.89% | -6.77 | -9.77 | 3.37 | -0.13 |
About Surgery Partners, Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
- CEO
- J. Eric Evans
- Employees
- 15K
- Beta
- 1.97
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($9.62 ÷ $14.27) − 1 = -32.59% (DCF, example).